Stuart Essig - 05 Jan 2023 Form 4/A - Amendment Insider Report for Orthofix Medical Inc. (OFIX)

Reporting relationship: Director
Issuer ticker: OFIX
Reported as of: 05 Jan 2023
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 09 Feb 2023, 16:55:12 UTC
Original report date: 09 Jan 2023
Prior SEC filing: 31 Jan 2023
Next SEC filing: 07 Apr 2023
Source filing: View source filing
Reporting owner signature: /s/ Patrick Keran, attorney-in-fact

Key filing fact

Stuart Essig filed Form 4/A - Amendment for Orthofix Medical Inc. (OFIX) on 09 Feb 2023.

Key facts

This page summarizes Stuart Essig's Form 4/A - Amendment filing for Orthofix Medical Inc. (OFIX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Feb 2023, 16:55.

Change

Previous filing in this sequence was filed on 31 Jan 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OFIX transaction

Common Stock

Award

Transaction value: $0
Shares: +14,354
Change %: +7.5%
Price: $0.000000
Shares after: 205,966
Date: 05 Jan 2023
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.

Footnote F2

This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.

Footnote F3

Includes 14,354 deferred stock units.